Dicot Pharma AB
DICOTBT | SPGR
Overview
Corporate Details
- ISIN(s):
- SE0011178458 (+1 more)
- LEI:
- 549300GX132RSE4OV407
- Country:
- Sweden
- Address:
- St Olofsgatan 11A, 753 21 Uppsala
- Website:
- https://www.dicotpharma.com/en/
- Sector:
- Health Care
- Industry:
- Pharmaceuticals
Description
Dicot Pharma is developing the drug candidate LIB-01, which is expected to be a potency drug to treat erectile dysfunction and premature ejaculation. Duration of action and fewer side effects are main desired properties. Dicot's main strategy is to develop LIB-01 in-house up to and including clinical phase 2a study, and then in partnership with major pharmaceutical companies to finance and further develop LIB-01 into a registered drug for the world market.
Market Data
Market Data Not Available
Last Price
Change / %
Market Cap
Market Cap data is planned for a future update.
N/A
Volume
Day High
Day Low
52W High
52W Low
Financials & KPIs
No data available
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
Chat, Summarize & Extract with AI!
You have of free filing views remaining.
Upgrade for unlimited access.
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| No filings match the current criteria. | ||||
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2024-09-12 | Tullbacken Aktiebolag | Other | Buy | 35,000 | 40,250.00 SEK |
| 2024-09-10 | Amandus Jabin | Other | Sell | 110,000 | 4,276,800.00 SEK |
| 2024-09-03 | Jörgen Larsson | Other | Other | 315,000 | N/A |
| 2024-09-02 | Patrick Lawlor | Other | Buy | 77,500 | 1,158,625.00 SEK |
| 2024-09-02 | Oskar Hellström | Other | Buy | 75,000 | 1,121,250.00 SEK |
| 2024-09-02 | Martin Walfisz | Other | Other | 2,108,718 | 442,830.78 SEK |
| 2024-08-31 | Bonny Heeren | Other | Other | 5,000,000 | 550,000.00 SEK |
| 2024-08-30 | Per-Anders Hedin | Other | Other | 5,000,000 | 110,000.00 SEK |
| 2024-08-30 | Erik Markus Näsholm | Other | Other | 2,000,000 | 42,600.00 SEK |
| 2024-08-30 | Greger Larsson | Other | Other | 1,600,000 | 34,080.00 SEK |
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
Hamlet BioPharma AB | Sweden | HAMLET | |
|
Harm Reduction Group AB | Sweden | NOHARM | |
|
Heidelberg Pharma AG | Germany | HPHA | |
|
HELLENIC DYNAMICS PLC | United Kingdom | HELD | |
|
HIKMA Pharmaceuticals PLC | United Kingdom | HIK | |
|
H. Lundbeck A | Denmark | HLUN | |
|
Hod-Assaf Industries Ltd. | Israel | HOD | |
|
HUDDLED GROUP PLC | United Kingdom | HUD | |
|
Iconovo AB | Sweden | ICO | |
|
iDNA Genomics Public Ltd | Cyprus | IDNA |